We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Erenumab
Australian Public Assessment Report
Device/Product Name
Aimovig
Active ingredients
Erenumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2017-02174-1-1
Submission Type
New biological entity
Decision
Approved